Pfizer
One of the world's largest pharmaceutical companies — vaccines, oncology, and the drug pipeline behind them.
Coverage of Pfizer is rising : 6 signals on the latest tracked day, up 50% from its three-week baseline of 4, across 3 domains (down from 4 a week ago). That makes it the #343 most-covered of the 348 concerns we track.
If Pfizer matters to your work, coverage is climbing off its baseline — worth a closer-than-usual look this week.
What’s changed
- STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more · STAT News — All Content · 2026-09-05
- Ionis’ rare neurology drug approved; Pfizer inks an ADC deal · BioPharma Dive — Latest News · 2026-09-05
- Pfizer NYC -> Pearl River Commute · Reddit r/biotech · 2026-08-29
- Trailing rivals, AbbVie scores win with dual-acting myeloma drug · BioPharma Dive — Latest News · 2026-09-05
- List of Determinations Including Written Request · FDA — What's New: Drugs · 2026-09-03
- Paxlovid did not help long Covid, study finds · STAT News — All Content · 2026-09-02
What the reporting says
Across 39 tracked stories from 16 outlets, reporting on Pfizer most often describes regulatory approvals (6), military action (1), treaties or agreements (1), launches or releases (1).
It shows up alongside Astrazeneca (18), Bristol Myers Squibb (19), Novartis (12), Regeneron (10), Gilead (11), Abstract (12), Eli Lilly (11), FDA (11).
Two steps out: Lung Cancer (through Astrazeneca, 13 shared stories on the weaker link); Catalyzex (through Abstract, 12 shared stories on the weaker link); Citations Loading (through Abstract, 12 shared stories on the weaker link); Citations Loading Bibliographic (through Abstract, 12 shared stories on the weaker link).
Tracked since Apr 12, with coverage on 18 separate days — concentrated in Society News and Biotech Pharma.